CopyPastehas never been so tasty!

Roche Diagnostics Medical Device Company Intelligence Report

by anonymous

  • 0
  • 0
  • 0
57 views

Headquartered in Basel, Switzerland, Roche Diagnostics is a division of F. Hoffmann-La Roche Ltd (Roche), the world’s largest biotech company with combined strengths in pharmaceuticals and diagnostics.

Roche Diagnostics is a leading player in in vitro diagnostics (IVD) – tests performed in a laboratory or at the point-of-care (PoC) on blood and other samples from patients – with a 20% share of the global market. It is also a leader in diabetes management. http://www.bharatbook.com/market-research-reports/medical-devices-market-research-report/roche-diagnostics-medical-device-company-intelligence-report.html

This profile focuses on Roche Diagnostics’ PoC activities (part of its Professional Diagnostics business), which produces coagulation monitoring systems, professional blood glucose testing and monitoring systems, cardiac marker testing devices, blood gas/electrolyte testing and urinalysis screening products, and its Diabetes Care business, which produces blood glucose monitoring and insulin delivery systems that are used in hospitals, doctors’ offices or patients’ homes for self-testing.

The principal activities of the Professional Diagnostics PoC and Diabetes Care businesses are located in Switzerland, the US, Germany and Austria.

In January 2012, Roche began focusing on expanding its coagulation testing product line in North America beyond physicians’ offices and out-patient clinics, with the development of a full line of coagulation analysers for hospitals and reference labs. To achieve this, the company acquired Verum Diagnostica, a Munich, Germany-based company focused on platelet function testing, which is claimed to be the fastest-growing field in the coagulation diagnostics market. The coagulation analyser product line is expected to be introduced in the US and Canada in 2014, subject to regulatory approval and other requirements. Further attempts to expand into North America were made in 2012 with the failed attempt to acquire Illumina Inc, a San Diego, California-based developer of life-science tools and integrated systems for the analysis of genetic variation and function (see Strategic Focus section). Roche believed this acquisition would have secured its position in the sequencing and microarrays market in North America.

In 2011, Roche Diagnostics was responsible for 22.9% of the Roche Group’s revenue.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Table of  Contents

OVERVIEW1
FINANCIAL REVIEW3
First Quarter 2012 Financial Results 3
2011 Financial Results 3
Professional Diagnostics6
Diabetes Care7
Molecular Diagnostics7
Applied Science7
Tissue Diagnostics8
Five-Year Financial Data 9
Outlook 10
Employees 10
STRATEGIC FOCUS11
Operational Excellence Programme11
R&D Strategy 12
PRODUCTS13
Recent Key Events 14
Coagulation Monitoring Systems17
Clinical Chemistry/Immunology Testing Solutions17
Blood Gas Testing Solutions 18
Blood Screening (PCR) 18
Cancer Screening 19
Cardiac Markers 20
Urinalysis Testing Solutions 21
Blood Glucose Testing Solutions 21
Insulin Pumps22
RESEARCH AND DEVELOPMENT 24
R&D Expenditure 24
R&D Activities 24
R&D Facilities 25
R&D Agreements 26
DexCom26
Uppsala BIO26
Merck 27
Clovis Oncology27
Rules-Based Medicine27
Genzyme and OSI Pharmaceuticals27
CapitalBio28
QIAGEN28
Trials and Studies 28
VISION Study28
ATHENA Study29
Accu-Chek 360° View STeP Study29
MANUFACTURING AND DISTRIBUTION31
AGREEMENTS 32
Panasonic Healthcare32
med fusion32
Gen-Probe33
Deutsches Krebsforschungszentrum/University Hospital Heidelberg 33
Cedars-Sinai Medical Center33
DexCom33
Karolinska University Hospital34
LabCorp34
Response Biomedical34
National Health Laboratory Services35
Lonza35
Eisai35
US Department of Defense35
Itamar Medical36
Fluidigm36
Alere36
InterComponentWare36
Exiquon37
Premier37
OraSure Technologies37
Dade Behring (Siemens)38
Iceland Genomics38
MERGERS AND ACQUISITIONS 39
Verum Diagnostica39
mtm laboratories39
PVT Probenverteiltechnik/PVT Lab Systems40
Medical Information Systems Assets40
Medingo40
Disetronic’s Infusion Systems Business41
Amira Medical41
AVL Medical 41
DIVESTITURES 42
Point-of-care non-clinical drugs-of-abuse testing business42
Point-of-care OPTI blood gas analyser product line 42
OTC pregnancy and ovulation self-testing business 42
LITIGATION 43
QIAGEN43
KEY CORPORATE EVENTS 44
 

For more information kindly visit :
Roche Diagnostics Medical Device Company Intelligence Report

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Add A Comment: